In a Los Angeles federal court, Dr. Salvador Plasencia received a 2 1/2-year prison sentence, along with probation and a fine, for providing ketamine to Matthew Perry, ultimately contributing to the actor’s fatal overdose. The judge emphasized that while Plasencia did not directly cause Perry’s death, he exploited the actor’s addiction for profit, leading to the outcome. During the emotional hearing, Perry’s family gave victim impact statements, expressing their grief and highlighting the profound loss. Plasencia, who pleaded guilty to distributing ketamine, apologized to Perry’s family, as the judge pushed back against the defense that Perry was his patient, viewing him instead as a drug dealer.
Read More
Jasveen Sangha, dubbed the “Ketamine Queen,” will plead guilty to federal drug charges related to Matthew Perry’s death, including distribution of ketamine resulting in death. According to the U.S. Attorney’s Office, Sangha faces a maximum sentence of 65 years in prison for her involvement in supplying Perry with ketamine in the weeks leading up to his fatal overdose, along with other distribution charges. The plea agreement states that Sangha, alongside others, including Perry’s assistant and an acquaintance, provided Perry with ketamine, with the assistant administering the fatal injections. This case underscores the dangers of unsupervised ketamine use, as well as the tragic consequences of addiction.
Read More
According to Michael Wolff, Donald Trump is reportedly claiming credit for tipping off The New York Times about Elon Musk’s alleged drug use, specifically ketamine, and other substances, as reported in May. Trump has been making disparaging remarks about Musk during phone calls with associates, fueled by the Tesla and SpaceX CEO’s opposition to a spending bill Trump is championing. This ongoing feud, and Musk’s threat to form a new political party, has intensified the conflict between the two, with Trump even suggesting Musk’s government subsidies could be jeopardized. Wolff’s claims are based on tracking Trump’s phone calls, while Trump’s communications director has previously refuted such claims.
Read More
Dr. Salvador Plasencia has agreed to plead guilty to four counts of distributing ketamine to Matthew Perry in the month before the actor’s death. This plea agreement, which includes dropping several other charges, stems from Plasencia illegally supplying Perry with ketamine, including administering injections at Perry’s home and instructing his assistant on its use. The plea carries a maximum 40-year sentence, although sentencing details remain unspecified. Co-defendant Jasveen Sangha, alleged to have supplied the fatal dose, has pleaded not guilty and awaits trial.
Read More
Following a New York Times exposé detailing his personal life, including alleged extensive drug use during a political campaign, Elon Musk vehemently denied the claims on X. The article cited sources and evidence, including photos and private messages, to support its reporting of Musk’s alleged use of ketamine, ecstasy, and psychedelic mushrooms. Separately, Musk is also accused of physically assaulting Treasury Secretary Scott Bessent. Despite these various allegations, Musk maintains he is not currently using drugs.
Read More
Following the recirculation of a video showing erratic behavior at a dinner, Elon Musk vehemently denied allegations of ketamine abuse. This denial contradicts previous public statements where Musk admitted to using ketamine under prescription to manage depression and improve his “brain chemistry.” The video, initially shared with claims of ketamine use, prompted a defense from Musk and others, including a claim that similar silverware manipulation is a family habit. The controversy unfolded amidst a New York Times report alleging Musk’s drug use during his time heading the Department of Government Efficiency.
Read More
Sources close to Elon Musk revealed to The New York Times that his alleged drug use during the 2024 election campaign, including ketamine, ecstasy, and psychedelic mushrooms, reportedly caused a bladder injury. Photographs viewed by the NYT also showed packaging labeled as Adderall in Musk’s possession. This alleged substance use coincided with concerns among associates regarding Musk’s erratic behavior and emotional instability. The report comes as Musk’s significant financial contribution and close ties to Donald Trump’s campaign are widely known.
Read More
A New York Times report alleges that Elon Musk, during his involvement in Donald Trump’s presidential campaign, intensively used ketamine, ecstasy, Adderall, and psychedelic mushrooms. This alleged drug use coincided with erratic behavior, including clashes with administration officials and a fixation on having more children. Musk’s subsequent appointment as head of the Department of Government Efficiency (DOGE) and his subsequent actions have been met with public scrutiny and numerous lawsuits. Despite these allegations, the White House continues to support DOGE’s mission and its ongoing work within the federal government.
Read More
A New York Times report reveals Elon Musk’s drug use was far more extensive than previously known, including frequent ketamine use to the point of bladder issues, along with other substances like ecstasy and psychedelic mushrooms. This aligns with earlier reports detailing erratic behavior during his time in the Trump administration, raising concerns among government officials about his drug use impacting public appearances and decision-making. Despite claims of infrequent ketamine use for depression and avoiding illegal drugs, the report suggests daily use and mixing with other substances. Musk’s departure from his White House role and reduced political spending coincide with this revelation.
Read More
John Q. Hosedrinker